Preview

Адипоцитокины: резистин и фактор некроза опухолей-α у мужчин с абдоминальным ожирением

https://doi.org/10.14341/2071-8713-5003

Полный текст:

Об авторах

С. А. Бутрова

Эндокринологический научный центр, Москва


Россия


Е. В. Ершова

Эндокринологический научный центр, Москва


Россия


А. В. Ильин

Эндокринологический научный центр, Москва


Россия


Список литературы

1. Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению. РМЖ. 2001;2(9):56-60.

2. Ожирение / под ред. Дедова И.И. и Мельниченко Г.А. — М., 2004.

3. Bo S., Gambino R., Pagani A., at al. Relationships between human serum resistin, inflammatory markers and insulin resistance. International Journal of Obesity. 2005;29:1315-1320.

4. Chandron M., Phillips S., Ciaraidi T. at al. Adiponectin: more then just another fat cell hormone? Diabetes Care. 2003;26:2442-2450.

5. Corica F., Allegra A., Corsonello A. et al. Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects. Int J Obes Relat Metab Disord. 1999;23(4):355-360.

6. Dalziel B., Gosby A, Richman R. et al. Association of the TNF- -308 G/A Promoter Polymorphism with Insulin Resistance in Obesity. Obesity Research. 2002;10:401-407.

7. Demirbas B., Guler S., Cakir B. et al. Plasma tumor necrosis factor-alpha levels and insulin resistance in nondiabetic hypertensive subjects. Horm Res. 2002;58(6):283-286.

8. Farvid M., Ng T., Chan D. et al. Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diabetes, Obesity and Metabolism. 2005;7(4):406-413.

9. Fruhbeck G., Gomez-Ambrosi J. et al. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. AJP Endocrinology and Metabolism. 2001;280:Е827-Е847.

10. Gabriele E. Sonnenberg, Glenn R. Krakower and Ahmed H. Kissebah. A Novel Pathway to the Manifestations of Metabolic Syndrome. Obesity Research. 2004;12:180-186.

11. Hotamisligil G.S. Molecular mechanism of insulin resistance and the role of the adipocyte. International Journal of Obesity. 2000; 4 (Suppl. 4):23-27.

12. Janke J., Engeli S., Gorzelniak K. et al. Resistin gene expression in human adipocytes is not related to insulin resistance. Obesity Research. 2002;10:1-5.

13. Krystyna M. Kras, Dorothy B. Hausman and Roy J. Martin. Tumor Necrosis Factor-Stimulates Cell Proliferation in Adipose Tissue-Derived Stromal-Vascular Cell Culture: Promotion of Adipose Tissue Expansion by Paracrine Growth Factors. Obesity Research. 2000;8:186-193.

14. Lais U. Monzillo, Osama Hamdy, Edward S. Horton at al. Effect of Lifestyle Modification on Adipokine Levels in Obese Subjects with Insulin Resistance. Obesity Research. 2003;11:1048-1054.

15. Matthews D., Hosker J., Rudenski A. at al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.

16. Ohya M., Taniguchi A., Fukushima M. et al. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients. Metabolism. 2005;54(10):1297-1301.

17. Rajala M., Qi Y., Patel Н. et al. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes. 2004;53(7):1671-1679.

18. Reilly M., Lehrke M., Wolfe M. et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005;111:932-939.

19. Shuldier A., Yang R., Gong D-W. Resistin, obesity and insulin resistance. N Engl J Med. 2001;345:1345-1346.

20. Smith U. Resistin - resistant to defining its role. Obesity Research. 2002;10:61-62.

21. Steppan C., Bailey S., Bhat S. et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307-312.

22. Ukkola O. Mini-review: Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander? European Journal of Endocrinology. 2002;147(5):571-574.

23. Zinman B., Hanley A.J., Harris S.B. et al. Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab. 1999; 4(1):272-278.


Для цитирования:


Бутрова С.А., Ершова Е.В., Ильин А.В. Адипоцитокины: резистин и фактор некроза опухолей-α у мужчин с абдоминальным ожирением. Ожирение и метаболизм. 2007;4(4):30-33. https://doi.org/10.14341/2071-8713-5003

For citation:


Butrova S.A., Ershova E.V., Il'in A.V. Adipotsitokiny: rezistin i faktor nekroza opukholey-α u muzhchin s abdominal'nym ozhireniem. Obesity and metabolism. 2007;4(4):30-33. (In Russ.) https://doi.org/10.14341/2071-8713-5003

Просмотров: 68


ISSN 2071-8713 (Print)
ISSN 2306-5524 (Online)